» Articles » PMID: 33684722

Rapid Quantification of Vincristine in Mouse Plasma Using ESI-LC-MS/MS: Application to Pharmacokinetic Studies

Overview
Publisher Elsevier
Date 2021 Mar 8
PMID 33684722
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A simple, rapid, and sensitive LC-MS/MS method for determining concentrations of the anticancer alkaloid vincristine in micro volumes of mouse plasma was developed and validated in positive ion mode. Separation of vincristine and the internal standard [H]-vincristine was achieved on an Accucore aQ column with a gradient mobile phase delivered at a flow rate of 0.4 mL/min and a run time of 2.2 min. Calibration curves were linear (r > 0.99, n = 8) up to 250 ng/mL, with a lower limit of quantitation of 2.5 ng/mL. The matrix effect and extraction recovery for vincristine were ranging 108-110% and 88.4-107%, respectively. The intra-day and inter-day precision of quality controls tested at 3 different concentrations were always less than 15%, and accuracy ranged from 91.7 to 107%. The method was successfully applied to evaluate the pharmacokinetic profile of vincristine in wild-type and CYP3A-deficient mice in support of a project to provide mechanistic insight into drug-drug interactions and to identify sources of inter-individual pharmacokinetic variability associated with vincristine-induced peripheral neuropathy.

Citing Articles

Pharmacokinetics, bioavailability and tissue distribution of chitobiose and chitotriose in rats.

Chen M, Jin J, Ji X, Chang K, Li J, Zhao L Bioresour Bioprocess. 2024; 9(1):13.

PMID: 38647841 PMC: 10991139. DOI: 10.1186/s40643-022-00500-y.


Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice.

Li Y, Kazuki Y, Drabison T, Kobayashi K, Fujita K, Xu Y Drug Metab Dispos. 2023; 52(2):80-85.

PMID: 38071551 PMC: 10801630. DOI: 10.1124/dmd.123.001466.


Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy.

Li Y, Drabison T, Nepal M, Ho R, Leblanc A, Gibson A JCI Insight. 2023; 8(14).

PMID: 37347545 PMC: 10443802. DOI: 10.1172/jci.insight.164646.


Development of the DNA-based voltammetric biosensor for detection of vincristine as anticancer drug.

Abbasi M, Alsaikhan F, Obaid R, Jahani S, Biroudian S, Oveisee M Front Chem. 2023; 10:1060706.

PMID: 36700073 PMC: 9870317. DOI: 10.3389/fchem.2022.1060706.


Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.

Nepal M, Taheri H, Li Y, Talebi Z, Uddin M, Jin Y Cancer Res Commun. 2022; 2(11):1334-1343.

PMID: 36506732 PMC: 9730833. DOI: 10.1158/2767-9764.crc-22-0172.


References
1.
Embree L, Gelmon K, Tolcher A, Hudon N, Heggie J, Dedhar C . Validation of a high-performance liquid chromatographic assay method for quantification of total vincristine sulfate in human plasma following administration of vincristine sulfate liposome injection. J Pharm Biomed Anal. 1998; 16(4):675-87. DOI: 10.1016/s0731-7085(97)00087-3. View

2.
FROST B, Lonnerholm G, Koopmans P, Abrahamsson J, Behrendtz M, Castor A . Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents. Acta Paediatr. 2003; 92(5):551-7. View

3.
Ong C, Coulter S, Birkett D, Bhasker C, Miners J . The xenobiotic inhibitor profile of cytochrome P4502C8. Br J Clin Pharmacol. 2001; 50(6):573-80. PMC: 2015019. DOI: 10.1046/j.1365-2125.2000.00316.x. View

4.
Guilhaumou R, Solas C, Rome A, Giocanti M, Andre N, Lacarelle B . Validation of an electrospray ionization LC/MS/MS method for quantitative analysis of vincristine in human plasma samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2010; 878(3-4):423-7. DOI: 10.1016/j.jchromb.2009.12.015. View

5.
van de Velde M, Kaspers G, Abbink F, Wilhelm A, Ket J, van den Berg M . Vincristine-induced peripheral neuropathy in children with cancer: A systematic review. Crit Rev Oncol Hematol. 2017; 114:114-130. DOI: 10.1016/j.critrevonc.2017.04.004. View